Although studies have established a relationship between hepatic RIPK3 levels and the severity of non-alcoholic fatty liver disease (NAFLD), the precise mechanisms through which RIPK3-dependent signaling contributes to the development of NAFLD remain unclear. This evidence concerns the gene RIPK3 and metabolic dysfunction-associated steatotic liver disease.